Related Articles
Clinicopathological characteristics of androgen-dependent advanced prostate cancer patients with α2-macroglobulin deficiency
Levels of acute inflammatory biomarkers in advanced prostate cancer patients with α2-macroglobulin deficiency
Blood‑based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer‑risk stratification
Evaluation of VEGF and PEDF in prostate cancer: A preliminary study in serum and biopsies
The auxiliary diagnostic value of prostate‑specific antigen and α‑methylacyl‑CoA racemase in prostate cancer